Hyderabad, May 15 (RAHNUMA): The Engineering Export Promotion Council (EEPC) of India on Friday organised a roadshow at ITC Kakatiya, Begumpet, as part of the lead-up to the second edition of Pharma MachTech & LabNext Expo 2026. The event featured interactive sessions focused on positioning India as a global innovation hub in the pharma machinery and laboratory equipment sectors.
The second edition of Pharma MachTech & LabNext Expo 2026 will be held from September 7 to 9, 2026, at Bharat Mandapam in New Delhi. The exhibition will be co-located with iPHEX, one of India’s leading global pharmaceutical expos. The events will showcase the complete pharma and healthcare engineering value chain on a common platform.
Addressing the gathering, chief guest Akshay S.C., Joint Director General of Foreign Trade (DGFT), Hyderabad Regional Authority, said the future growth of India’s pharmaceutical sector depends significantly on the strength of the domestic steel and manufacturing industries. He stressed the need for manufacturers to align with global market requirements and accelerate indigenous production of specialised machinery.
Earlier, Adhip Mitra, Executive Director and Secretary of EEPC India, said India aims to increase pharmaceutical exports to USD 130 billion by 2030, requiring manufacturers and exporters to focus on value-driven and innovation-led excellence.
He noted that Pharma MachTech & LabNext Expo 2026 would provide opportunities to explore emerging technologies such as Pharma 4.0, automation, precision drug delivery systems, and advanced laboratory equipment. He added that seminars, conferences, and buyer-seller meetings with international delegations would facilitate knowledge sharing and global business opportunities.
A seminar on “Transforming Pharma & Biotech Industries through Smart Manufacturing and Next-Gen Laboratory Solutions” was also organised during the roadshow. Rakesh Suraj made a presentation on Pharma MachTech and LabNext Expo 2026, while industry experts discussed government initiatives, sustainability, digital transformation, and advanced manufacturing practices in the sector.
The Hyderabad roadshow assumes significance as the city contributes nearly one-third of the global vaccine supply and around 40 per cent of India’s bulk drug production. Engineering clusters such as Jeedimetla, Balanagar, and Kukatpally continue to serve as key components of the pharmaceutical engineering supply chain.
India’s domestic pharma machinery sector is currently growing at a CAGR of 8–10 per cent, though it remains dependent on imports for high-end equipment. Pharma machinery exports have grown at a CAGR of 15.3 per cent over the past five years, while imports grew at 10.5 per cent, resulting in a negative trade balance. Similarly, laboratory equipment exports grew at 8.3 per cent CAGR, while imports rose by 7 per cent during the same period.
The event concluded with a vote of thanks by Arun Shukla, Deputy regional chairman of EEPC India, who appreciated the participation of industry leaders and stakeholders. The programme also witnessed the presence of Pankaj Chadha, K. Narendran of CDSCO, and Suresh Babu.
